Breast Cancer in Men: A Single Center Experience Over a Period of 22 years.
CONCLUSIONS: MBC has increasing incidence. PR-negative status was associated with better overall survival and disease-free interval. Indications to radiotherapy and hormonal therapy need standardization and will benefit from prospective randomized control trials.
PMID: 32147980 [PubMed - in process]
Source: The Israel Medical Association Journal - Category: General Medicine Tags: Isr Med Assoc J Source Type: research
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Carcinoma in Situ | Chemotherapy | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | General Medicine | HER2 | Hormonal Therapy | Hormones | Israel Health | Male Breast Cancer | Mastectomy | Middle East Health | Rare Diseases | Skin | Study | Women